By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Endo Pharmaceuticals 

1400 Atwater Drive

Malvern  Pennsylvania  19355  U.S.A.
Phone: 484-216-0000 Fax: n/a



Company News
Endo Pharma (ENDP) Caves To The FDA, Agrees To Yank Opana ER From Market 7/7/2017 6:05:36 AM
First Time Ever: FDA Asks Endo Pharma (ENDP) to Stop Selling Opana ER Amid Opioid Crisis 6/9/2017 5:53:53 AM
Endo Pharma (ENDP) Issues Voluntary Nationwide Recall For One Lot Of Edex (Alprostadil For Injection) 10 Mcg 2 Pack Carton Due To Potential Lack Of Sterility Assurance 2/27/2017 6:25:52 AM
BioDelivery (BDSI) Closes Transaction To Reacquire License To BELBUCA From Endo Pharma (ENDP) 1/9/2017 8:41:57 AM
BioDelivery (BDSI) Reacquires License To BELBUCA From Endo Pharma (ENDP) 12/8/2016 8:49:15 AM
Endo Pharma (ENDP) Presents New Phase 2 Data Evaluating The Safety And Effectiveness Of XIAFLEX (Collagenase Clostridium Histolyticum) For Dupuytren's Disease Nodules 9/30/2016 8:16:49 AM
Endo Pharma (ENDP) Announces FDA Advisory Committee Meeting For OPANA ER 6/15/2016 9:45:17 AM
Investors Concerned as Endo Pharma (ENDP) Mimics the Path of Valeant (VRX) 5/9/2016 6:44:45 AM
Endo Pharma (ENDP) to Cut 740 Employees and Shakes Up U.S. Senior Management in Restructuring 5/6/2016 6:08:50 AM
FTC Sues Endo Pharma (ENDP) for Allegedly Paying Off Generic Drugmakers 4/1/2016 6:49:29 AM